A new multiomic framework refines the search for Alzheimer’s causal genes
Researchers have developed a new computational method, PRISM-xQTL, to pinpoint the causal genes and molecular mechanisms behind genetic risk factors for Alzheimer’s disease. The framework integrates data from multiple molecular levels—including gene expression, DNA methylation, and protein levels—to analyze genetic variants shared between Alzheimer’s and immune disorders. It identified specific genes, such as FCER1G, where non-coding genetic variants exert regulatory effects, providing a clearer link between genetic risk, immune signaling, and disease pathology.
Why it might matter to you:
This methodological advance directly addresses a core challenge in your field: moving from genetic association to actionable biological insight. The multiomic, systems-level approach demonstrated here could serve as a blueprint for validating and prioritizing blood-based proteomic biomarkers in neurodegenerative diseases. It highlights a pathway for integrating disparate data streams—genomic, proteomic, and clinical—to build more robust and clinically actionable diagnostic frameworks.
Stay curious. Stay informed — with
Science Briefing.
Always double check the original article for accuracy.
